Research Funded To Date

The Galactosemia Foundation has awarded over $601,000 to fund galactosemia related research.


  • Towards individual prognostication in Classic Galactosemia

Dr. Annet Bosch


  • Defining the role of Galactitol accumulation as a possible mediator of outcome in GALT null fruit flies

Dr. Fridovich-Keil


  • Developing small molecule therapy for Classic Galactosemia by crystallography-based fragment screening 

Dr. Wyatt Yue


  • Untargeted analysis of the Galactosemia micro-biome 

Dr. Sandy Van Calcar



  • Intervention and outcomes in classic galactosemia

Dr. Judith L. Fridovich-Keil


  • In Vivo Efficacy and Safety Assessment of Small Molecule Inhibitors of Human Galactokinase

Dr. Kent Lai


Dr. Annet Bosch



Dr. Gerard Berry


Dr. Judith L. Fridovich-Keil


Dr. Kent Lai


Dr. Sanda Van Calcar



  • Evaluation of Nutrition Recommendations for Classic Galactosemia

Sandra Van Calcar


  • The Brain and Neuro-functioning in Adults with Galactosemia

Dr. Susan Waisbren


  • Computational Biology Strategy for the Development of Potential Drugs for People with Classical Galactosemia

Dr. Anna Marabotti



  • Health and Psychosocial Outcomes in Adults with Classic Galactosemia

Dr. Gerard Berry


  • Galactosemia: Review of Outcomes and Development of Guidelines for Management of Educational and Behavioral Challenges

Dr. Susan Waisbren



Dr. Judith L. Fridovich-Keil